Author

Moataz A. Soliman

Observed names: Moataz Alsayed Soliman, Soliman, Moataz A.

Institution: Prince Sattam Bin Abdulaziz University

Observed institutions: Suez Canal University, Prince Sattam Bin Abdulaziz University, Taibah University

ORCID: 0000-0003-2330-5889

Observed ORCID: 0000-0003-2330-5889

OpenAlex ID: A5102946602

Design, Synthesis and Anticancer Screening of Novel Benzothiazole-Piperazine-1,2,3-Triazole Hybrids

2018 · Mohamed R. Aouad, Moataz A. Soliman, et al. · Molecules · 72

Synthesis, Characterization, DNA Binding, Docking, and Anticancer Studies of Novel Bis‐1,2,3‐triazoles Phthalonitrile

2020 · Shaya Yahya Alraqa, Moataz Alsayed Soliman, et al. · ChemistrySelect · 27

Novel bis-benzimidazole-triazole hybrids: anticancer study, in silico approaches, and mechanistic investigation

2024 · Moataz A. Soliman, Hany E. A. Ahmed, et al. · Future Medicinal Chemistry · 19

Novel Benzimidazole‐1,2,3‐Triazole Hybrids: Synthesis, Dual Antimicrobial, Anticancer Activity, Mechanistic Insights, and Computational Studies

2025 · Moataz A. Soliman, Elsayed H. Eltamany, et al. · ChemistrySelect · 15

Nanogel delivered benzimidazole-triazole hybrids as potent multitarget inhibitors of topoisomerase and tubulin in triple-negative breast cancer

2025 · Sara A. Almadani, Mohamed A.M. Ali, et al. · Bioorganic Chemistry · 8

Synthesis, Characterization, and Antimicrobial Screening of Novel 1,2,4-Triazoles, 1,3,4-Thiadiazoles, and 1,3,4-Oxadiazoles Bearing the Indole Moiety

2019 · Adeeb A. Ali, Moataz A. Soliman, et al. · Organic Preparations and Procedures International · 8

From chemistry to targeted cancer therapy: potent benzimidazole-1,2,3-triazole hybrid-loaded nanogels against breast and colorectal malignancies

2025 · Azizah M. Malebari, Mohamed A. M. Ali, et al. · RSC Advances · 5

Synthesis, Antimicrobial and Antitumor Activity of Some 3, 5-Diaryl and 1, 3, 5-Triaryl-2-Pyrazoline Derivatives

2011 · Zeinab H. Ismaeil, Moataz A. Soliman, et al. · 4

Design and synthesis of mono- and/or bis-(glycosylated 1,2,3-triazole)-benzimidazole hybrids as Dual InhA/ MurB Inhibitors with Potent Antimycobacterial Activity

2026 · Moataz A. Soliman, Elsayed H. Eltamany, et al. · Journal of Molecular Structure · 1

Corrigendum to “Nanogel delivered benzimidazole-triazole hybrids as potent multitarget inhibitors of topoisomerase and tubulin in triple-negative breast cancer” [Bioorg. Chem. 167 (2025) 109288]

2025 · Sara A. Almadani, Mohamed A.M. Ali, et al. · Bioorganic Chemistry

Works count: 11

Citation count: 159

H-index: 6

I10-index: 4